Handelsinvest Investeringsforvaltning Sells 242 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Handelsinvest Investeringsforvaltning cut its position in shares of UnitedHealth Group Incorporated (NYSE:UNH – Get Rating) by 2.4% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 9,747 shares of the healthcare conglomerate’s stock after selling 242 shares during the period. Handelsinvest Investeringsforvaltning’s holdings in UnitedHealth Group were worth $4,923,000 at the end of the most recent quarter.

Other institutional investors also recently modified their holdings of the company. TimeScale Financial Inc. increased its stake in shares of UnitedHealth Group by 276.9% during the 3rd quarter. TimeScale Financial Inc. now owns 49 shares of the healthcare conglomerate’s stock worth $25,000 after purchasing an additional 36 shares during the last quarter. Pflug Koory LLC grew its stake in UnitedHealth Group by 160.0% in the 3rd quarter. Pflug Koory LLC now owns 52 shares of the healthcare conglomerate’s stock valued at $26,000 after buying an additional 32 shares during the last quarter. Urban Wealth Management LLC acquired a new position in UnitedHealth Group in the 2nd quarter valued at about $29,000. Knott David M Jr acquired a new position in UnitedHealth Group in the 2nd quarter valued at about $29,000. Finally, Belmont Capital LLC grew its stake in UnitedHealth Group by 294.1% in the 3rd quarter. Belmont Capital LLC now owns 67 shares of the healthcare conglomerate’s stock valued at $34,000 after buying an additional 50 shares during the last quarter. 86.31% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other UnitedHealth Group news, EVP Erin Mcsweeney sold 450 shares of the firm’s stock in a transaction on Wednesday, December 7th. The shares were sold at an average price of $542.30, for a total value of $244,035.00. Following the completion of the sale, the executive vice president now directly owns 8,736 shares in the company, valued at $4,737,532.80. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 0.40% of the company’s stock.

Analysts Set New Price Targets

UNH has been the topic of a number of research reports. Royal Bank of Canada upped their price target on shares of UnitedHealth Group from $588.00 to $592.00 and gave the company an “outperform” rating in a research note on Monday, October 17th. UBS Group decreased their target price on shares of UnitedHealth Group from $590.00 to $550.00 and set a “neutral” rating on the stock in a research report on Wednesday, January 18th. Loop Capital increased their target price on shares of UnitedHealth Group from $575.00 to $590.00 in a research report on Tuesday, January 17th. Raymond James lowered shares of UnitedHealth Group from a “strong-buy” rating to an “outperform” rating and set a $615.00 target price on the stock. in a research report on Monday, November 21st. Finally, Deutsche Bank Aktiengesellschaft increased their target price on shares of UnitedHealth Group from $615.00 to $617.00 and gave the stock a “buy” rating in a research report on Tuesday. Three research analysts have rated the stock with a hold rating, twelve have given a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $599.39.

UnitedHealth Group Trading Up 0.1 %

Shares of NYSE UNH opened at $492.25 on Wednesday. UnitedHealth Group Incorporated has a 52-week low of $445.73 and a 52-week high of $558.10. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.82 and a current ratio of 0.77. The firm has a 50 day moving average price of $518.45 and a two-hundred day moving average price of $524.08. The stock has a market cap of $459.93 billion, a P/E ratio of 23.20, a price-to-earnings-growth ratio of 1.36 and a beta of 0.73.

UnitedHealth Group (NYSE:UNH – Get Rating) last posted its quarterly earnings data on Friday, January 13th. The healthcare conglomerate reported $5.34 earnings per share for the quarter, topping the consensus estimate of $5.17 by $0.17. UnitedHealth Group had a net margin of 6.21% and a return on equity of 27.04%. The company had revenue of $82.79 billion during the quarter, compared to analysts’ expectations of $82.53 billion. During the same period in the prior year, the company posted $4.48 earnings per share. UnitedHealth Group’s revenue for the quarter was up 12.3% compared to the same quarter last year. As a group, equities analysts forecast that UnitedHealth Group Incorporated will post 24.9 EPS for the current year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, December 13th. Shareholders of record on Monday, December 5th were issued a $1.65 dividend. This represents a $6.60 dividend on an annualized basis and a yield of 1.34%. The ex-dividend date of this dividend was Friday, December 2nd. UnitedHealth Group’s payout ratio is 31.15%.

About UnitedHealth Group

(Get Rating)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.